Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 36.71% is 35% above its 5-year average of 27.15%, near the high end of its 5-year range (11.29%–37.24%).
As of the fiscal period ended Tuesday, March 31, 2026. 10.14% above its 12-month average of 33.33%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
36.71%
EBITDA MARGIN AVG TTM
33.33%
EBITDA MARGIN AVG 3Y
31.97%
EBITDA MARGIN AVG 5Y
27.15%
EBITDA MARGIN AVG 10Y
28.05%
EBITDA MARGIN AVG 15Y
29.55%
EBITDA MARGIN AVG 20Y
32.07%
CURRENT VS TTM AVG
+10.14%
CURRENT VS 3Y AVG
+14.81%
CURRENT VS 5Y AVG
+35.21%
CURRENT VS 10Y AVG
+30.85%
CURRENT VS 15Y AVG
+24.20%
CURRENT VS 20Y AVG
+14.47%
Market Cap
$133.37B
EBITDA Margin
36.80%
TTM Avg
38.33%
3Y Avg
39.88%
5Y Avg
39.69%
Market Cap
$137.13B
EBITDA Margin
30.87%
TTM Avg
31.21%
3Y Avg
32.47%
5Y Avg
31.98%
Market Cap
$124.86B
EBITDA Margin
24.22%
TTM Avg
25.63%
3Y Avg
25.70%
5Y Avg
26.23%
Market Cap
$124.82B
EBITDA Margin
35.99%
TTM Avg
34.83%
3Y Avg
32.83%
5Y Avg
33.22%
Market Cap
$121.09B
EBITDA Margin
41.14%
TTM Avg
20.45%
3Y Avg
32.86%
5Y Avg
36.27%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AstraZeneca PLC (AZN) | $131.47B | 36.71% | 33.33% | 31.97% | 27.15% |
| CVS Health Corp. (CVS)vs › | $133.25B | 3.73% | 3.63% | 4.02% | 4.83% |
| Bristol-Myers Squibb Company (BMY)vs › | $133.37B | 36.80% | 38.33% | 39.88% | 39.69% |
| Danaher Corporation (DHR)vs › | $137.13B | 30.87% | 31.21% | 32.47% | 31.98% |
| Stryker Corporation (SYK)vs › | $124.86B | 24.22% | 25.63% | 25.70% | 26.23% |
| Intuitive Surgical, Inc. (ISRG)vs › | $124.82B | 35.99% | 34.83% | 32.83% | 33.22% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $121.09B | 41.14% | 20.45% | 32.86% | 36.27% |
| Pfizer Inc. (PFE)vs › | $142.54B | 32.51% | 34.72% | 32.84% | 32.73% |
| Medtronic plc (MDT)vs › | $109.30B | 25.92% | 26.11% | 25.62% | 25.51% |
| GSK plc (GSK)vs › | $103.56B | 32.61% | 26.78% | 28.16% | 28.64% |
Gross Margin
81.7%
EBITDA Margin
36.7%
Operating Margin
23.7%
Net Margin
17.2%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-03-31 | 36.71% |
| 2025-12-31 | 28.96% |
| 2025-09-30 | 33.78% |
| 2025-06-30 | 33.87% |
| 2025-03-30 | 36.49% |
| 2024-12-31 | 18.47% |
| 2024-09-30 | 28.92% |
| 2024-06-30 | 31.11% |
| 2024-03-31 | 34.47% |
| 2023-12-31 | 21.30% |
| 2023-09-30 | 28.16% |
| 2023-06-30 | 32.69% |
| 2023-03-31 | 37.24% |
| 2022-12-31 | 20.95% |
| 2022-09-30 | 23.48% |
| 2022-06-30 | 17.60% |
| 2022-03-31 | 19.20% |
| 2021-12-31 | 15.82% |
| 2021-09-30 | 11.29% |
| 2021-06-30 | 22.87% |
| 2021-03-31 | 36.78% |
| 2020-12-31 | 30.82% |
| 2020-09-30 | 29.98% |
| 2020-06-30 | 31.78% |
| 2020-03-31 | 32.44% |
| 2019-12-31 | 33.31% |
| 2019-09-30 | 22.99% |
| 2019-06-30 | 20.95% |
| 2019-03-31 | 32.29% |
| 2018-12-31 | 42.68% |
| 2018-09-30 | 29.01% |
| 2018-06-30 | 28.07% |
| 2018-03-31 | 27.13% |
| 2017-12-31 | 31.04% |
| 2017-09-30 | 28.95% |
| 2017-06-30 | 30.51% |
| 2017-03-31 | 29.14% |
| 2016-12-31 | 55.92% |
| 2016-09-30 | 28.76% |
| 2016-06-30 | 15.88% |
| 2016-03-31 | 26.28% |
| 2015-12-31 | 28.19% |
| 2015-09-30 | 29.29% |
| 2015-06-30 | 25.99% |
| 2015-03-31 | 29.42% |
| 2014-12-31 | 10.06% |
| 2014-09-30 | 21.06% |
| 2014-06-30 | 26.72% |
| 2014-03-31 | 23.96% |
| 2013-12-31 | 29.43% |
| 2013-09-30 | 33.50% |
| 2013-06-30 | 34.32% |
| 2013-03-31 | 32.08% |
| 2012-12-31 | 37.46% |
| 2012-09-30 | 43.42% |
| 2012-06-30 | 35.71% |
| 2012-03-31 | 36.18% |
| 2011-12-31 | 36.24% |
| 2011-09-30 | 58.50% |
| 2011-06-30 | 41.23% |
| 2011-03-31 | 47.36% |
| 2010-12-31 | 43.15% |
| 2010-09-30 | 38.09% |
| 2010-06-30 | 42.37% |
| 2010-03-31 | 47.15% |
| 2009-12-31 | 34.66% |
| 2009-09-30 | 44.72% |
| 2009-06-30 | 41.66% |
| 2009-03-31 | 46.07% |
| 2008-12-31 | 34.41% |
| 2008-09-30 | 39.25% |
| 2008-06-30 | 36.88% |
| 2008-03-31 | 38.54% |
| 2007-12-31 | 30.37% |
| 2007-09-30 | 36.18% |
| 2007-06-30 | 32.20% |
| 2007-03-31 | 36.46% |
| 2006-12-31 | 33.98% |
| 2006-09-30 | 37.37% |
| 2006-06-30 | 36.78% |
| 2006-03-31 | 36.54% |
| 2005-12-31 | 32.29% |
| 2005-09-30 | 34.51% |
| 2005-06-30 | 33.25% |
| 2005-03-31 | 30.68% |
| 2004-12-31 | -44.65% |
| 2004-09-30 | 27.79% |
| 2004-06-30 | 25.62% |
| 2004-03-31 | 26.69% |
| 2003-12-31 | 25.42% |
| 2003-09-30 | 33.01% |
| 2003-06-30 | 23.32% |
| 2003-03-31 | 32.61% |
| 2002-12-31 | 21.05% |
| 2002-09-30 | 26.63% |
| 2002-06-30 | 30.06% |
